Differential regulatory role of soluble klothos on cardiac fibrogenesis in hypertension

Xue Liu, Yuanjian Chen, Cody W. Mccoy, Tieqiang Zhao, Leigh Quarles, Min Pi, Syamal Bhattacharya, Gwendalyn King, Yao Sun

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND Soluble Klotho functions as an endocrine factor that plays important roles in a variety of pathophysiological processes. Soluble Klotho contains 130 KDa and 65 KDa isoforms. However, their distinct individual functional heterogeneity remains uncertain. Herein, we investigated the regulatory role of two soluble Klothos on cardiac fibrogenic responses. METHODS AND RESULTS The effect of soluble Klothos on myofibroblast differentiation, proliferation, and collagen synthesis/degradation were examined in cultured mouse cardiac myofibroblasts. The role of 130 KDa Klotho on fibrosis in hypertensive heart disease were examined in wild type (WT) and Klotho transgenic (Tg/+) mice receiving chronic angiotensin (Ang)II infusion. Our in vitro studies revealed that addition of 130 KDa soluble Klotho isoform increased collagen synthesis in a dose dependent manner. Furthermore, 130 KDa Klotho significantly stimulated myofibroblast differentiation, proliferation, and ERK phosphorylation, which were abolished by fibroblast growth factor (FGF) receptor antagonist (SU5402). In contrast, 65 KDa soluble Klotho treatment significantly suppressed myofibroblast proliferation and collagen synthesis. In vivo study further demonstrated that chronic AngII infusion lead to cardiac fibrosis in both WT and Tg/+ mice. However, cardiac collagen, TGF-β1, TIMP-2, and α-smooth muscle actin (SMA) levels were markedly upregulated in Tg/+ mice compared to WT cohort. CONCLUSION Taken together, these findings implicate that 130 KDa soluble Klotho plays a stimulatory role in cardiac myofibroblast growth and activity through FGF pathway, whereas 65 KDa soluble Klotho exerts an anti-fibrotic effect in cardiac myofibroblasts. Thus, two distinct isoforms of soluble Klotho appear to play the counter-regulatory roles in cardiac fibrogenic responses.

Original languageEnglish (US)
Pages (from-to)1140-1147
Number of pages8
JournalAmerican journal of hypertension
Volume29
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Myofibroblasts
Hypertension
Collagen
Protein Isoforms
Fibrosis
Tissue Inhibitor of Metalloproteinase-2
Fibroblast Growth Factor Receptors
Fibroblast Growth Factors
Angiotensin II
Transgenic Mice
Smooth Muscle
Actins
Heart Diseases
Phosphorylation
Growth

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Differential regulatory role of soluble klothos on cardiac fibrogenesis in hypertension. / Liu, Xue; Chen, Yuanjian; Mccoy, Cody W.; Zhao, Tieqiang; Quarles, Leigh; Pi, Min; Bhattacharya, Syamal; King, Gwendalyn; Sun, Yao.

In: American journal of hypertension, Vol. 29, No. 10, 01.10.2016, p. 1140-1147.

Research output: Contribution to journalArticle

Liu, Xue ; Chen, Yuanjian ; Mccoy, Cody W. ; Zhao, Tieqiang ; Quarles, Leigh ; Pi, Min ; Bhattacharya, Syamal ; King, Gwendalyn ; Sun, Yao. / Differential regulatory role of soluble klothos on cardiac fibrogenesis in hypertension. In: American journal of hypertension. 2016 ; Vol. 29, No. 10. pp. 1140-1147.
@article{78fdec834ece4421b2e1022c7cbfe0b4,
title = "Differential regulatory role of soluble klothos on cardiac fibrogenesis in hypertension",
abstract = "BACKGROUND Soluble Klotho functions as an endocrine factor that plays important roles in a variety of pathophysiological processes. Soluble Klotho contains 130 KDa and 65 KDa isoforms. However, their distinct individual functional heterogeneity remains uncertain. Herein, we investigated the regulatory role of two soluble Klothos on cardiac fibrogenic responses. METHODS AND RESULTS The effect of soluble Klothos on myofibroblast differentiation, proliferation, and collagen synthesis/degradation were examined in cultured mouse cardiac myofibroblasts. The role of 130 KDa Klotho on fibrosis in hypertensive heart disease were examined in wild type (WT) and Klotho transgenic (Tg/+) mice receiving chronic angiotensin (Ang)II infusion. Our in vitro studies revealed that addition of 130 KDa soluble Klotho isoform increased collagen synthesis in a dose dependent manner. Furthermore, 130 KDa Klotho significantly stimulated myofibroblast differentiation, proliferation, and ERK phosphorylation, which were abolished by fibroblast growth factor (FGF) receptor antagonist (SU5402). In contrast, 65 KDa soluble Klotho treatment significantly suppressed myofibroblast proliferation and collagen synthesis. In vivo study further demonstrated that chronic AngII infusion lead to cardiac fibrosis in both WT and Tg/+ mice. However, cardiac collagen, TGF-β1, TIMP-2, and α-smooth muscle actin (SMA) levels were markedly upregulated in Tg/+ mice compared to WT cohort. CONCLUSION Taken together, these findings implicate that 130 KDa soluble Klotho plays a stimulatory role in cardiac myofibroblast growth and activity through FGF pathway, whereas 65 KDa soluble Klotho exerts an anti-fibrotic effect in cardiac myofibroblasts. Thus, two distinct isoforms of soluble Klotho appear to play the counter-regulatory roles in cardiac fibrogenic responses.",
author = "Xue Liu and Yuanjian Chen and Mccoy, {Cody W.} and Tieqiang Zhao and Leigh Quarles and Min Pi and Syamal Bhattacharya and Gwendalyn King and Yao Sun",
year = "2016",
month = "10",
day = "1",
doi = "10.1093/ajh/hpw062",
language = "English (US)",
volume = "29",
pages = "1140--1147",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Differential regulatory role of soluble klothos on cardiac fibrogenesis in hypertension

AU - Liu, Xue

AU - Chen, Yuanjian

AU - Mccoy, Cody W.

AU - Zhao, Tieqiang

AU - Quarles, Leigh

AU - Pi, Min

AU - Bhattacharya, Syamal

AU - King, Gwendalyn

AU - Sun, Yao

PY - 2016/10/1

Y1 - 2016/10/1

N2 - BACKGROUND Soluble Klotho functions as an endocrine factor that plays important roles in a variety of pathophysiological processes. Soluble Klotho contains 130 KDa and 65 KDa isoforms. However, their distinct individual functional heterogeneity remains uncertain. Herein, we investigated the regulatory role of two soluble Klothos on cardiac fibrogenic responses. METHODS AND RESULTS The effect of soluble Klothos on myofibroblast differentiation, proliferation, and collagen synthesis/degradation were examined in cultured mouse cardiac myofibroblasts. The role of 130 KDa Klotho on fibrosis in hypertensive heart disease were examined in wild type (WT) and Klotho transgenic (Tg/+) mice receiving chronic angiotensin (Ang)II infusion. Our in vitro studies revealed that addition of 130 KDa soluble Klotho isoform increased collagen synthesis in a dose dependent manner. Furthermore, 130 KDa Klotho significantly stimulated myofibroblast differentiation, proliferation, and ERK phosphorylation, which were abolished by fibroblast growth factor (FGF) receptor antagonist (SU5402). In contrast, 65 KDa soluble Klotho treatment significantly suppressed myofibroblast proliferation and collagen synthesis. In vivo study further demonstrated that chronic AngII infusion lead to cardiac fibrosis in both WT and Tg/+ mice. However, cardiac collagen, TGF-β1, TIMP-2, and α-smooth muscle actin (SMA) levels were markedly upregulated in Tg/+ mice compared to WT cohort. CONCLUSION Taken together, these findings implicate that 130 KDa soluble Klotho plays a stimulatory role in cardiac myofibroblast growth and activity through FGF pathway, whereas 65 KDa soluble Klotho exerts an anti-fibrotic effect in cardiac myofibroblasts. Thus, two distinct isoforms of soluble Klotho appear to play the counter-regulatory roles in cardiac fibrogenic responses.

AB - BACKGROUND Soluble Klotho functions as an endocrine factor that plays important roles in a variety of pathophysiological processes. Soluble Klotho contains 130 KDa and 65 KDa isoforms. However, their distinct individual functional heterogeneity remains uncertain. Herein, we investigated the regulatory role of two soluble Klothos on cardiac fibrogenic responses. METHODS AND RESULTS The effect of soluble Klothos on myofibroblast differentiation, proliferation, and collagen synthesis/degradation were examined in cultured mouse cardiac myofibroblasts. The role of 130 KDa Klotho on fibrosis in hypertensive heart disease were examined in wild type (WT) and Klotho transgenic (Tg/+) mice receiving chronic angiotensin (Ang)II infusion. Our in vitro studies revealed that addition of 130 KDa soluble Klotho isoform increased collagen synthesis in a dose dependent manner. Furthermore, 130 KDa Klotho significantly stimulated myofibroblast differentiation, proliferation, and ERK phosphorylation, which were abolished by fibroblast growth factor (FGF) receptor antagonist (SU5402). In contrast, 65 KDa soluble Klotho treatment significantly suppressed myofibroblast proliferation and collagen synthesis. In vivo study further demonstrated that chronic AngII infusion lead to cardiac fibrosis in both WT and Tg/+ mice. However, cardiac collagen, TGF-β1, TIMP-2, and α-smooth muscle actin (SMA) levels were markedly upregulated in Tg/+ mice compared to WT cohort. CONCLUSION Taken together, these findings implicate that 130 KDa soluble Klotho plays a stimulatory role in cardiac myofibroblast growth and activity through FGF pathway, whereas 65 KDa soluble Klotho exerts an anti-fibrotic effect in cardiac myofibroblasts. Thus, two distinct isoforms of soluble Klotho appear to play the counter-regulatory roles in cardiac fibrogenic responses.

UR - http://www.scopus.com/inward/record.url?scp=84991087081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991087081&partnerID=8YFLogxK

U2 - 10.1093/ajh/hpw062

DO - 10.1093/ajh/hpw062

M3 - Article

C2 - 27543985

AN - SCOPUS:84991087081

VL - 29

SP - 1140

EP - 1147

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 10

ER -